Sparrow Clinical Research Institute

Lansing, Michigan 48912-1811

6 studies enrolling now · 64 studies all time

What they study most

ASCVD, Acute Coronary Syndrome, Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Acute Respiratory Distress Syndrome, Aortic Stenosis, Aortic Valve Stenosis, Arrhythmia, Arrhythmias, Cardiac, Arterial Occlusive Diseases, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation

Studies at this site

• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) — Recruiting now
• The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation. — Recruiting now
• Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement — Recruiting now
• Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
• Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation — Completed
• Portico Next Generation Approval Study — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• CREST-2 Long-term Observational Extension Study — Running, not enrolling
• Aveir DR i2i Study — Completed
• The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System — Completed
• Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome — Enrolling by invitation
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
• SyncAV Post-Market Trial — Running, not enrolling
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
• Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
• Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling
• Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Evaluation in STEMI Patients Using FDY-5301 — Completed
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial — Running, not enrolling
• CanGaroo® Registry Study — Completed
• Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome — Running, not enrolling
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
• A Registry for Patients Taking Uptravi — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study — Completed
• Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). — Stopped early
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment — Stopped early
• The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke — Completed
• Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period — Completed
• AdaptResponse Clinical Trial — Completed
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome — Completed
• Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO) — Withdrawn before enrolling
• Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome — Withdrawn before enrolling
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
• St.Jude Medical Cardiac Lead Assessment Study — Completed
• Heart Sounds Registry — Completed
• SILtuximab in Viral ARds (SILVAR) Study — Stopped early
• MultiPoint Pacing™ Post Market Study — Completed
• A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study — Completed